On this page you find WASOG Task Force Papers. These documents include articles and clinical practice guidelines, policy statements, and research statements, developed by multi disciplary experts on ILD collaborating in WASOG Task Forces.
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28: 56-64
Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med 2013, 19:545–561
Practical eminence and experience-based recommendations for use of tnf-α inhibitors in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31; 91-107